3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Xeroderma Pigmentosum
1
Uterine Cervical Dysplasia
1
Trichothiodystrophy Syndromes
1
Squamous Intraepithelial Lesions
1
Sexuality
1
Oligodendroglioma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hematopoietic and Lymphatic System Neoplasm
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Glioma
1
Glioblastoma
1
Endometrial Neoplasms
1
DNA Repair-Deficiency Disorders
1
Cockayne Syndrome
1
Carcinoma, Endometrioid
1
Breast Cancer Survivors
1
Bone Neoplasms
1
Atypical Squamous Cells of the Cervix
1
Astrocytoma
1
Interventions
Gemcitabine
57
130-nm albumin-bound paclitaxel
35
Specimen Handling
26
Magnetic Resonance Spectroscopy
21
Albumin-Bound Paclitaxel
21
Fluorouracil
20
Leucovorin
19
Irinotecan
19
Oxaliplatin
17
Biopsy
17
Taxes
16
pembrolizumab
13
Cyclophosphamide
11
Cisplatin
11
fludarabine
10
Cetuximab
9
Capecitabine
8
Nivolumab
7
Carboplatin
7
irinotecan sucrosofate
6
durvalumab
6
dehydroftorafur
6
Radiosurgery
6
Pemetrexed
6
olaparib
5
Ipilimumab
5
Erlotinib Hydrochloride
5
trastuzumab deruxtecan
4
aldesleukin
4
Radiotherapy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pancreatic Neoplasms
×
Restraint, Physical
×
90 days
×
Clear all
No trials found.